The Clinical Significance of Follow Up SCC Levels in Patients with Recurrent Squamous Cell Carcinoma of the Cervix
![]() |
Choi Young Min
(Department of Radiation Oncology, Pusan Paik Hospital, College of Medicine, Inje University)
Park Sung Kwang (Department of Radiation Oncology, Pusan Paik Hospital, College of Medicine, Inje University) Cho Heung Lae (Department of Radiation Oncology, Pusan Paik Hospital, College of Medicine, Inje University) Lee Kyoung Bok (Department of Obstetrics and Gynecology, Pusan Paik Hospital, College of Medicine, Inje University) Kim Ki Tae (Department of Obstetrics and Gynecology, Pusan Paik Hospital, College of Medicine, Inje University) Kim Juree (Department of Radiation Oncology, Sanggye Paik Hospital) Sohn Seung Chang (Department of Radiation Oncology, Sanggye Paik Hospital) |
1 | Duk JM, Groenier KH, de Bruijn HW, et aI. Pretreatment serum squamous cell carcinoma antigen : a newly identified prognostic factor in early-stsge cervical carcinoma. J CIin Oncol 1996;14(1):111-118 |
2 | Hong JH, Tsai CS, Chang JT, et aI. The prognostic significance of pre- and posttreatment SCC levels in patients with squamous cell carcinoma of the cervix treated by radiotherapy. Int J Radiat Oncol Biol Phys 1998;41(4):823-830 DOI PUBMED ScienceOn |
3 | Takeshima N, Hirai Y, Katase K, Yano K, Yamauchi K, Hasumi K. The value of squamous cell carcinoma antigen as a predictor of nodal metastasis in cervical cancer. Gynecol Oncol 1998;68(3):263-266 DOI ScienceOn |
4 | Duk JM, van Voorst Vader PC, ten Hoor KA, HoIIema H, DoegIas HM, de Bruijn HW. Elevated levels of squamous cell carcinoma antigen in patients with a benign disease of the skin. Cancer 1989;64(8):1652-1656 DOI ScienceOn |
5 | Micke O, Prott FJ, Schafer U, Tangerding S, Potter R, WiIIich N. The inpact of squamous cell carcinoma (SCC) antigen in the follow-up after radiotherapy in patients with cervical cancer. Anticancer Res 2000;20(6D):5113-5115 PUBMED |
6 | Choi DH, Kim ES, Nam KH. A study of relationship between the level of serum SCC antigen and recurrence patterns after treatment of uterine cervix cancer. J Korean Soc Ther Radiol 1999;17(2):120-128 |
7 | Esajas MD, Duk JM, de Bruijn HW, et aI. Clinical value of routine serum squamous cell carcinoma antigen in followup of patients with early-stage cervical cancer. J CIin Oncol 2001;19(19):3960-3966 |
8 | Pras E, WiIIemse PH, Canrinus AA, et aI. Serum squamous cell carcinoma antigen and CYFRA 21-1 in cervical cancer treatment. Int J Radiat Oncol Biol Phys 2002;52(1):23-32 DOI PUBMED ScienceOn |
9 | de Bruijn HW, Duk JM, van der Zee AG, et aI. The cIinical value of squamous cell carcinoma antigen in cancer of the uterine cervix. Tumour Biol 1998;19(6):505-516 DOI ScienceOn |
10 | FiIeIIa X, Cases A, MoIina R, et aI. Tumor markers in patients with chronic renal failure. Int J Biol Markers 1990;5(2):85-88 |
11 | Duk JM, de Bruijn HW, Groenier KH, et aI. Cancer of the uterine cervix: sensitivity and specificity of serum aquamous cell carcinoma antigen determinations. Gynecol Oncol 1990;39(2);186-194 |
12 | Gaarenstroom KN, Bonfrer JM, Korse CM, Kenter GG, Kenemans P. Value of Cyfra 20-1, TPA, and SCC-Ag in predicting extracervical disease and prognosis in cervical cancer. Anticancer Res 1997;17(4B):2955-2958 |
13 | Lin H, ChangChien CC, Huang EY, Tseng CW, Eng HL, Huang CC. The role of pretreatment squamous cell carcinoma antign in predicting nodal metastasis in early stage cervical cancer. Acta Obstet Gynecol Scand 2000;79(2):140-144 DOI ScienceOn |
14 | Maiman M. The cIinical appIication of serum squamous cell carcinoma antigen level monitoring in invasive cervical carcinoma. Gynecol Oncol 2002;84(1):4-6 DOI PUBMED ScienceOn |
15 | Kato H, Torigoe T. Radioimmunoassay for tumor antigen of human cervical squamous cell carcinoma. Cancer 1977;40:1621-1628 DOI ScienceOn |
16 | Ngan HY, Cheung AN, Lauder IJ, Wong LC, Ma HK. Prognostic significance of serum tumour markers in carcinoma of the cervix. Eur J Gynaecol Oncol 1996;17(6):512-517 PUBMED |
17 | De Pita O, FrezzoIini A, Cianetti A, De Sanctis G, Fontana L, Bottari V. Squamous cell carcinoma-related antigen (SCCr-Ag), slCAM-1 and beta 2-microglobulin are useful markers of disease activity in psoriasis. Acta Derm Vanereoa 1999;79(2):132-135 DOI |
18 | Rose PG, Baker S, Fournier L, NeIson BE, Hunter RE. Serum squamous cell carcinoma antigen levels in invasive cervical cancer: prediction of response and recurrence. Am J Obstet Gynecol 1993;168:942-6 PUBMED |
19 | BoIIi JA, Doering DL, Bosscher JR, et aI. Squamous cess carcinoma antigen : clinical utility in squamous cell carcinoma antigen : clinical utility in squamous cell carcinoma of the uterine cervix. Gynecol Oncol 1994;55(2):169-173 DOI ScienceOn |
20 | Maruo T, Yoshida S, Samoto T, et aI. Factors regulating SCC antigen expression in squamous cell carcinoma of the uterine cervix. Tumour Biol 1998;19(6):494-504 DOI ScienceOn |
21 | Brioschi PA, Bischof P, DeIafosse C, Krauer F. Squamous-cell carcinoma antigen (SCC-A) values related to clinical outcome of pre-invasive and invasive cervical carcinoma. Int J Cancer 1991;47(3):376-379 DOI PUBMED |
22 | HoIIoway RW, To A, Moradi M, Boots L, Watson N, ShingIeton HM. Monitoring the course of cervical carcinoma with the squamous cell carcinoma serum radioimmunoassay. Obstet Gynecol 1989;74(6):944-949 |
23 | AvaII-Lundqvist EH, SjovaII K, NiIsson BR, Eneroth PH. Prognnostio significance of pretreatment serum levels of squamous cell carcinoma antigen and CA 125 in cervical carcinoma. Eur J Cancer 1992;28A(10):1695-1702 |
24 | Chan YM, Ng TY, Ngan HY, Wong LC. Monitiring of serum squamous cell carcinoma antigen levels in invasive cervical cancer: is it cost-effective? Gynecol Oncol 2002;84(1):7-11 |
![]() |